Holen Sie sich die Stockscreener-App
450.09
0.12%
-1.14
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $184.18 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
January 2025 Options Now Available For Vertex Pharmaceuticals (VRTX) - Nasdaq
PNC Financial Services Group Inc. Increases Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded to "Buy" Rating by StockNews.com - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Holdings Lifted by Advisors Asset Management Inc. - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Portfolio Design Labs LLC - MarketBeat
EULAV Asset Management Has $14.65 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Jennison Associates LLC - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Holdings Trimmed by MWA Asset Management - MarketBeat
57,825 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Segall Bryant & Hamill LLC - MarketBeat
Northwest Bancshares Inc. Has $6.10 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Strategy Asset Managers LLC Sells 1,805 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Pathstone Holdings LLC Purchases 2,112 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Quest Partners LLC - MarketBeat
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by W.G. Shaheen & Associates DBA Whitney & Co - MarketBeat
1,424 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Whalen Wealth Management Inc. - MarketBeat
First Turn Management LLC Trims Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Thrivent Financial for Lutherans Sells 3,119 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by OneDigital Investment Advisors LLC - MarketBeat
Vertex Pharmaceuticals Inc. stock rises Monday, still underperforms market - MarketWatch
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Braun Stacey Associates Inc. - MarketBeat
3 Growth Stocks You Can Buy Right Now Without Any Hesitation - The Motley Fool
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Swiss National Bank - MarketBeat
Atlanta Consulting Group Advisors LLC Purchases 1,331 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Empowered Funds LLC Sells 17,482 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Natixis Advisors LLC - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Lifted by Mizuho Securities USA LLC - MarketBeat
Kentucky Retirement Systems Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
CIBC Asset Management Inc Acquires 4,432 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Impax Asset Management Group plc Has $3.46 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Broderick Brian C Increases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Huntington National Bank - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Rating Upgraded by Citigroup - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stake Increased by KBC Group NV - MarketBeat
Citigroup Initiates Coverage of Vertex Pharmaceuticals (VRTX) with Buy Recommendation - MSN
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Gilead, Vertex initiated as new big biotech buys at Citi - Seeking Alpha
Vertex Pharmaceuticals Shows Rising Relative Strength; Still Shy Of Key Benchmark - MSN
Sivik Global Healthcare LLC Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Aubrey Capital Management Ltd Takes Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Earns Buy Rating from Analysts at Citigroup - MarketBeat
Pinnacle Financial Partners Inc Grows Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex’s upcoming sciatica trial readout is a high-stakes moment in its quest to quell pain - STAT
Vertex Pharmaceuticals' SWOT analysis: cystic fibrosis leader faces pipeline tests - Investing.com
Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP & CFO C - GuruFocus.com
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Chase Investment Counsel Corp Has $3.28 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Victory Capital Management Inc. Lowers Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Aptus Capital Advisors LLC Buys 3,071 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Baillie Gifford & Co. Lowers Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
WealthPlan Investment Management LLC Takes $635,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity - sharewise
Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Rating Upgraded by StockNews.com - MarketBeat
Vertex Pharmaceuticals CEO sells $7.83 million in stock - Investing.com
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Cumberland Partners Ltd - MarketBeat
Hemenway Trust Co LLC Has $18.66 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Boosts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Los Angeles Capital Management LLC Decreases Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Mayflower Financial Advisors LLC - MarketBeat
Atria Investments Inc Sells 1,564 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
SpiderRock Advisors LLC Grows Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Fiera Capital Corp Has $2.86 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
6,307 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by CWA Asset Management Group LLC - MarketBeat
Lindbrook Capital LLC Raises Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Assetmark Inc. Has $94.91 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
Galvin Gaustad & Stein LLC Decreases Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat
0.15%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):